ICKSMCB 2020 / 2020 International Conference of the Korean Society for Molecular and Cellular Biology / September 17(Mon)-19(Wed), 2020 / COEX, Seoul, Korea

LUNCHEON SYMPOSIA

HOME > Program > Luncheon Symposium

GenScript Biotech Corporation (Stock Code: 1548.HK)

October 6 (Tue), 12:10-12:20, Tamna Hall A



GenScript Biotech Corp. is a world leader in the biological reagent service industry. Headquartered in New Jersey, USA, the Group currently has a couple of R&D, production and operation centers in Nanjing and New Jersey, two production bases in Zhenjiang and Jinan, two European bases for its subsidiary Legend in Netherlands and Ireland, and a wholly-owned subsidiary in Japan.

With the fast growth in developing biological reagents, the Company now expands its business into immunotherapy, contract development and manufacturing organization (CDMO), lab equipment and industrial microbiology applications. To support these businesses, it has established open and innovation-driven technological platforms, GMP facilities for pre-clinical drug discovery and pharmaceutical product development and a full-range industrial microbial R&D and industrialization platform for enzyme screening, GMP plasmid and virus production, antibody drug discovery (Bispecific antibodies technology; Hybridoma technology; Humanized Antibody technology; Phage display technology), genetic engineering, protein engineering and fermentation process optimization. The Company is uniquely positioned and well equipped to further fulfill its mission in making people and nature healthier through biotechnology.